期刊
BIOORGANIC CHEMISTRY
卷 110, 期 -, 页码 -出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bioorg.2021.104784
关键词
Naegleria; Therapeutics; HMG-CoA; Type 2 statins; Programmed cell death; Encephalitis
资金
- Instituto de Salud Carlos III, Spain [PI18/01380]
- RICET from Programa Redes Tematicas de Investigacion Cooperativa, FIS (Ministerio Espanol de Salud, Madrid, Spain) [RD16/0027/0001]
- FEDER
- Agustin de Betancourt Programme (Cabildo de Tenerife, TFinnova Programme by FDCAN fund)
- Agustin de Betancourt Programme (Cabildo de Tenerife, TFinnova Programme by MEDI fund)
- Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI)
Primary Amoebic Encephalitis caused by Naegleria fowleri is a deadly infection affecting mainly children and young adults, often contracted during aquatic activities. Recent research suggests that statins, particularly type 2 statins, may be a promising treatment option for PAM, as they have shown to eliminate N. fowleri trophozoites and induce programmed cell death.
Primary Amoebic Encephalitis due to Naegleria fowleri species is a fatal infection of the Central Nervous System mostly affecting children and young adults. Infections often occur after performance of risk activities in aquatic habitats such as swimming and splashing. PA?s therapy remain a key issue to be solved which needs an urgent development. Recently, statins have been highlighted as possible novel compounds to treat PAM. Furthermore, type 2 statins due to improved pharmacological properties and lower toxicity could be use in the future. In the present work, three type 2 statins were checked for their activity against two type strains of N. fowleri. In addition, the effects at the cellular level triggered in treated amoebae were checked in order to evaluate if programmed cell death was induced. The obtained results showed that the tested statins, rosuvastatin, pitavastatin and cerivastatin were able to eliminate N. fowleri trophozoites and also induced PCD. Therefore, type 2 statins could be used in the near future for the treatment of PAM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据